Implanet SA

Equities

ALIMP

FR0013470168

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:24:09 2024-04-26 am EDT			5-day change	1st Jan Change
0.0712 ^EUR	-2.73%		+0.28%	+11.25%

Apr. 10	Implanet: first-quarter sales up slightly	CF
Apr. 09	Implanet S.A. Reports Revenue Results for the First Quarter of 2024	CI

Implanet S.A. Reports Revenue Results for the Fourth Quarter and Full Year 2023

January 15, 2024 at 12:00 pm EST

Implanet S.A. reported revenue results for the fourth quarter and full year 2023. For the quarter, the Company reported revenue of ?1,643,000 against ?2,053,000 a year ago.

For the year 2023, the Company reported revenue of ?7,448,000, compared with annual revenue of ?8,027,000 in 2022.

Latest news about Implanet SA

Implanet: first-quarter sales up slightly	Apr. 10	CF
Implanet S.A. Reports Revenue Results for the First Quarter of 2024	Apr. 09	CI
Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 06	CI
Implanet S.A. Announces Board Changes	Mar. 06	CI
Implanet Completes EUR5.5 Million Capital Raise	Feb. 05	MT
Implanet S.A. announced that it has received ?5 million in funding from Shanghai Sanyou Medical Co., Ltd	Feb. 01	CI
Implanet S.A. Reports Revenue Results for the Fourth Quarter and Full Year 2023	Jan. 15	CI
Sanyou Medical Eyes Controlling Stake in French Peer Implanet For Up to 5 Million Euros	Dec. 11	MT
Implanet S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-10	CI
Implanet: share price soars, fund-raising reassures investors	23-09-28	CF
Implanet Shares Soar Amid EUR5 Million Funding Deal with Sanyou Medical	23-09-28	MT
Implanet S.A. announced that it expects to receive ?5 million in funding from Shanghai Sanyou Medical Co., Ltd	23-09-27	CI
Implanet Launches New Minimally Invasive Screw System for Spine Surgeries in Europe	23-06-22	MT
IMPLANET Announces the European Launch of the MIS Range, a Minimally Invasive Pedicle Screw System	23-06-21	CI
Implanet S.A. Appoints David FAN to the Board of Directors	23-05-04	CI
Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
France's Implanet Wins US FDA Nod for Anterior Cervical Cage	23-04-11	MT
Implanet S.A. Signs an Exclusive Distribution Contract for SMTP Technology Co.’s Ultrasonic Surgical Scalpel in France	22-11-22	CI
IMPLANET Signs a Distribution Agreement With Shanghai Sanyou Medical Co, Ltd. in China and a Technological Partnership for the Development of a New Product Range	22-11-16	CI
Implanet Raises $3 Million Via Shares, Warrants Issue; Sanyou Medical Boosts Stake to 29%	22-10-20	MT
Implanet S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-20	CI
Implanet S.A. Reports Revenue for the Second Quarter and First Half of 2022	22-07-11	CI
Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Medical	22-06-29	CI
Implanet S.A. Announces Consolidated Revenue Results for the First Quarter of 2022	22-04-19	CI
Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-15	CI

Chart Implanet SA

Duration

Period

More charts

Company Profile

Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - spine surgery (94.9%); - knee surgery and arthroscopy (1%). The balance of net sales (4.1%) concerns the medical equipment distribution activity. Net sales are distributed geographically as follows: France (47.1%), Europe/Middle East/Africa (14.3%), the United States (18.5%) and other (20.1%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-08 - Q2 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
IMPLANET SA	+11.25%	9.5M
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-9.04%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B

Medical Devices & Implants